caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1912933524

Kreton MavromatisMD

Interventional CardiologyDecatur, GAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Kreton Mavromatis's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Vasilis Babaliaros
Interventional Cardiology · Atlanta, GA
65162
Stamatios Lerakis
Cardiology · New York, NY
4692
Gerard Mcgorisk
Internal Medicine · Atlanta, GA
2161
Bradley Leshnower
Cardiac Surgery · Atlanta, GA
1737
John Roback
Pathology · Atlanta, GA
1227
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
63
Unique beneficiaries
—
Total services
77
Distinct HCPCS
4
Medicare payment
$3K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 155 Interventional Cardiology providers in GA — bottom quintile (cohort median 1,839).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
187
Beneficiaries
—
Total drug cost
$26K
Distinct drugs
9
Brand share
10.7%
Top prescribed drugs
Metoprolol Succinate33 claims
Carvedilol33 claims
Rosuvastatin Calcium32 claims
Apixaban20 claims
Ezetimibe18 claims
QUALITY · MIPS · 2024
Final MIPS score
94.5
Quality
80.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.82%
APM Entity